Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology
NCT ID: NCT02558907
Last Updated: 2017-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2015-09-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?
NCT03299855
Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.
NCT07297121
Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder
NCT03581643
Self-screening of Cognitive Impairment in Primary Care
NCT04019665
Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients
NCT07122856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cognitive evaluation by MMS (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) tests
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with cancer (solid tumor or hematological) for which a 1st line treatment is planned
* Patient candidate an oncogeriatric assessment
* Patient agreeing to participate in the study
* French language
* Lack of subsequent neurological sequelae with cognitive impact stroke, dementia or progressive psychiatric disorder
* Patient having a life expectancy ≥ 6 months
Exclusion Criteria
* Patients unable to meet the cognitive tests
* Refusal to participate
* Realization of a MMSE or MoCA test in the last 6 months
71 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Francois Baclesse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heidi LAVIEC, MD
Role: PRINCIPAL_INVESTIGATOR
Centre François Baclesse - CAEN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU
Caen, , France
Centre François Baclesse
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MoCA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.